Quarterly report pursuant to Section 13 or 15(d)

Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative)

v3.7.0.1
Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Dec. 31, 2015
Note 1 - Company And Summary Of Significant Accounting Policies Details Narrative        
Accumulated deficit $ (126,964,000)   $ (124,649,000)  
Cash and cash equivalent $ 235,000 $ 30,000 $ 19,000 $ 47,000
Diluted shares excluded from calcuation of EPS 254,434,453 22,663,098    
Research and development $ 144,000 $ 225,000